Stocks extend decline; Dow down 320 points, or 1%, Factory activity in New York decelerates for fourth straight month in January, U.K. insurers drop after London high court rules that they must pay out over COVID-19, GE stock price target raised to $14 from $12 at UBS. View the real-time PBH price chart on Robinhood and decide if you want to buy or sell commission-free. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. The Dow Closed in Bear Market After WHO Declares Pandemic, Lululemon and 3 Other Stocks That Could Pop, According to Analysts, FDA warns that pain-relieving teething products are unsafe, asks companies to stop selling them, Prestige Brands posts loss on impairment charge, Here are Wall Street’s 19 favorite mid-cap stocks for 2018, Small-cap fund manager tunes out market ‘noise’ in bid to find quality companies, Dow books 7th straight weekly gain in muted preholiday trade, Dow opens lower but remains on track for 7th straight weekly gain, Prestige Brands to buy enema maker Fleet for $825 million, Prestige Brands earnings boosted by OTC sales, Prestige Brands revenue climbs, but outlook soft, Apple to issue $10 billion to $12 billion of bonds to finance share buybacks, dividends, Prestige Brands profit up 31% on strong demand, Raymond James Sticks to Their Hold Rating for Prestige Brand Holdings (PBH), Prestige Brand Holdings (PBH) Receives a Hold from D.A. KushCo: A Cannabis Stock That Could be Fire, Defi Is The Next Generation For Cryptocurrency Investors, Village Farms International (NASDAQ: VFF) Stock is a Unique Cannabis ESG Play, JP Morgan Chase (NYSE:JPM) Is A Buy On Post-Earnings Weakness, Buy Pure Storage (NASDAQ: PSTG) Stock on Pullback Levels Here, Exxon’s (NYSE:XOM) 7% Yield Is A Buy And Hold For 2021, Here’s Where to Buy Dropbox (NASDAQ: DBX) Shares on Pullbacks, 3 Stocks that Could Ride the Blue Wave to Big Gains, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. Prestige Consumer Healthcare's stock was trading at $35.91 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Chloraseptic® #1 Sore Throat Relief Brand. Prestige Consumer Healthcare updated its FY22 earnings guidance on Thursday, November, 5th. PRESTIGE CONSUMER HEALTHCARE INC. : Forcasts, revenue, earnings, analysts expectations, ratios for PRESTIGE CONSUMER HEALTHCARE INC. Stock | PBH | Prestige Consumer Healthcare is a non-value accretive roll-up of OTC Healthcare consumer products. Something went wrong while loading Watchlist. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. We are a company of brand builders. Find the latest Prestige Consumer Healthcare In (PBH) stock quote, history, news and other vital information to help you with your stock trading and investing. Prestige Consumer Healthcare's stock is owned by many different institutional and retail investors. Get the latest Prestige Consumer Healthcare In (PBH) stock news and headlines to help you in your trading and investing decisions. The company provided EPS guidance of approx $3.18 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.25. BidaskClub upgraded shares of Prestige Consumer Healthcare (NYSE:PBH) from a sell rating to a hold rating in a research report report published on Thursday, BidAskClub reports. Prestige Consumer Healthcare does not have a long track record of dividend growth. DA Davidson dropped their target price on shares of […] BidaskClub upgraded shares of Prestige Consumer Healthcare (NYSE:PBH) from a sell rating to a hold rating in a research report report published on Thursday, BidAskClub reports.. Other equities research analysts have also issued reports about the stock. Copyright © 2021 MarketWatch, Inc. All rights reserved. Prestige Consumer Healthcare Inc. (formerly Prestige Brands, Inc.) markets, sells, manufactures and distributes consumer healthcare products to retail outlets in the US, Canada, Australia and certain international markets. Top institutional shareholders include Wedge Capital Management L L P NC (0.50%), Dalton Greiner Hartman Maher & Co. (0.24%), Diversified Trust Co (0.03%) and State of Alaska Department of Revenue (0.02%). BidaskClub upgraded shares of Prestige Consumer Healthcare (NYSE:PBH) from a sell rating to a hold rating in a report issued on Thursday, BidAskClub reports.. A number of other equities research analysts have also recently commented on PBH. Prestige Consumer Healthcare's stock was trading at $35.91 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. This browser is no longer supported at MarketWatch. Their forecasts range from $39.00 to $125.00. The high price target for PBH is $125.00 and the low price target for PBH is $39.00. View which stocks have been most impacted by COVID-19. Other research analysts have also issued research reports about the company. Prestige Consumer Healthcare Inc. (PBH) Stock Price: $34.97 USD-0.23 (-0.65%) Updated December 30, 4:00 PM EST - Market closed. Prestige Consumer Healthcare Inc. (PBH) - free report >> Published in ZER Report. Prestige Consumer Healthcare's mailing address is 660 WHITE PLAINS ROAD SUITE 250, TARRYTOWN NY, 10591. Volume today is low. Prestige Consumer Healthcare Inc., formerly Prestige Brands Holdings, Inc. is engaged in the marketing, sales and distribution of over-the-counter healthcare products. Want to see which stocks are moving? Prestige Consumer Healthcare Inc (PBH) stock is lower by -4.80% over the last 12 months, and the average rating from Wall Street analysts is a Buy. Get short term trading ideas from the MarketBeat Idea Engine. Are financial markets closed for Martin Luther King Day? Includes articles, videos and real-time news from StockTwits. One share of PBH stock can currently be purchased for approximately $37.78. Prestige Consumer Healthcare Inc. (PBH) Stock Price: $35.45 USD 1.35 (3.96%) Updated November 10, 12:11 PM EST - Market open. Spruce Point Capital Management Releases A Strong Sell Research Opinion On Prestige Consumer Healthcare Inc. (NYSE: PBH) PR Newswire NEW YORK, June 30, 2020 NEW YORK , June 30, 2020 /PRNewswire/ -- Report entitled "Time To Nix Management" outlines how Prestige Consumer Healthcare Inc. ("PBH", "Prestige" or "the Company") faces 40%-60% downside risk to … Some companies that are related to Prestige Consumer Healthcare include The Estée Lauder Companies (EL), Herbalife Nutrition (HLF), Nu Skin Enterprises (NUS), Medifast (MED), Inter Parfums (IPAR), USANA Health Sciences (USNA), Veru (VERU), Revlon (REV) and Nature's Sunshine Products (NATR). The P/E ratio of Prestige Consumer Healthcare is 12.64, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.50. Since then, PBH shares have decreased by 2.9% and is now trading at $34.87. Prestige Consumer Healthcare had a return on equity of 13.81% and a net margin of 15.84%. The company offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids/lozenges, Clear Eyes for eye allergies/redness relief, Compound W wart removals, Debrox ear wax removals, DenTek for PEG oral care, and Dramamine for motion sickness relief. Intraday Data provided by FACTSET and subject to terms of use. The Prestige Consumer Healthcare 52-week high stock price is … Since then, PBH stock has increased by 5.2% and is now trading at $37.78. Prestige Consumer Healthcare does not currently pay a dividend. PEG Ratios above 1 indicate that a company could be overvalued. 7 Wall Street analysts have issued ratings and price targets for Prestige Consumer Healthcare in the last 12 months. You may vote once every thirty days. Prestige Consumer Healthcare has a market capitalization of $1.89 billion and generates $963.01 million in revenue each year. This suggests that while the debt levels are significant, we'd stop short of calling them problematic. View analysts' price targets for Prestige Consumer Healthcare or view Wall Street analyst' top-rated stocks. Learn everything you need to know about successful options trading with this three-part video course. Prestige Consumer Healthcare has received 461 “outperform” votes. Delta Air Lines or Southwest Airlines: Which Is a Better Buy As Vaccines Roll Out? Please log in to your account or sign up in order to add this asset to your watchlist. Prestige Consumer Healthcare employs 520 workers across the globe. A Decision on Tariffs Rests With Biden. View Prestige Consumer Healthcare Inc. PBH investment & stock information. Cookie Notice. The stock has traded between $35.91 and $36.78 so far today. PBH stock was sold by a variety of institutional investors in the last quarter, including Dalton Greiner Hartman Maher & Co., Wedge Capital Management L L P NC, Diversified Trust Co, and State of Alaska Department of Revenue. Learn more. Read More . Prestige Consumer Healthcare, Inc. () Stock Market info Recommendations: Buy or sell Prestige Consumer Healthcare stock? The Company operates through two segments: North American Over-the-Counter (OTC) Healthcare, and International Over-the-Counter Healthcare. They currently have $125.00 price objective on the stock. DA Davidson dropped their price objective on shares of Prestige Consumer Healthcare from $45.00 to $39.00 and set […] Prestige Consumer Healthcare (NYSE:PBH) was upgraded by analysts at BidaskClub from a “sell” rating to a “hold” rating in a research note issued to investors on Friday, BidAskClub reports. Davidson, Prestige Consumer Healthcare downgraded to market perform from outperform at Raymond James, Prestige Brands upgraded to outperform from market perform at Raymond James. Of course Prestige Consumer Healthcare may not be the best stock to buy. Read More . View our earnings forecast for Prestige Consumer Healthcare. This price target is based on 7 analysts offering 12 month price targets for Prestige Consumer Healthcare in the last 3 months. Prestige Consumer Healthcare (NYSE:PBH) Given New $103.00 Price Target at CIBC marketbeat.com - November 9 at 11:16 AM: Prestige Consumer Healthcare (NYSE:PBH) Lowered to "Hold" at Zacks Investment Research marketbeat.com - October 12 at 12:40 PM: Prestige Consumer Healthcare (NYSE:PBH) Lowered to Neutral at DA Davidson For the millions of people who rely on BC® Powder's fast relief, our new on-the-go stick packs deliver the same fast pain relief in a more convenient, sealed stick pack. Get the latest news and breaking stories for Prestige Consumer Healthcare (PBH) stock. Privacy Notice, and Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York. Other equities research analysts have also issued reports about the stock. Look for Chloraseptic® and its soothing lozenges, fast-acting sprays, or kids spray in cherry, wild berries or other flavors. On average, they anticipate Prestige Consumer Healthcare's share price to reach $80.17 in the next twelve months. Identify stocks that meet your criteria using seven unique stock screeners. PBH’s rank also includes a short-term technical score of 23. So far 239,696 shares have traded compared to average volume of 398,876 shares. The company's average rating score is 2.43, and is based on 3 buy ratings, 4 hold ratings, and no sell ratings. Detailed balance sheet for Prestige Consumer Healthcare stock (PBH), including cash, debt, assets, liabilities, and book value. Fortunately, Prestige Consumer Healthcare grew its EBIT by 4.6% in the last year, slowly shrinking its debt relative to earnings. Prestige Consumer Healthcare is an American company that distributes branded over-the-counter healthcare and household cleaning products to … Prestige Consumer Healthcare Inc (PBH) stock is trading at $36.08 as of 11:32 AM on Friday, Dec 18, a decline of -$0.11, or -0.3% from the previous closing price of $36.19. Distributed by Public, unedited and unaltered, on 12 January 2021 13:21:09 UTC ... Stock quotes are provided by Factset, Morningstar and S&P Capital IQ Prestige Consumer Healthcare has received a consensus rating of Hold. Volume today is light. Skip to content. Interested parties can register for or listen to the call using this link or dial in at Not Available. XL Fleet (NYSE:XL) Stock: The Next Big EV Company? BC® Powder Pain Relievers FAST PAIN RELIEF FOR TOUGH HEADACHES AND PAIN JUST GOT A LOT EASIER. However, analysts commonly use some key metrics to help gauge the value of a stock. Skip to content. For the best MarketWatch.com experience, please update to a modern browser. * *Based on IRI units sold. Get the latest Prestige Consumer Healthcare In (PBH) stock news and headlines to help you in your trading and investing decisions. Prestige Consumer Healthcare Inc. (formerly Prestige Brands, Inc.) markets, sells, manufactures and distributes consumer healthcare products to retail outlets in the US, Canada, Australia and certain international markets. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Top institutional investors include Wedge Capital Management L L P NC (0.50%), Dalton Greiner Hartman Maher & Co. (0.24%), Diversified Trust Co (0.03%) and State of Alaska Department of Revenue (0.02%). Wall Street Stock Market & Finance report, prediction for the future: You'll find the Prestige Consumer Healthcare share forecasts, stock quote and buy / sell signals below.According to present data Prestige Consumer Healthcare's PBH shares and potentially its … BidaskClub upgraded shares of Prestige Consumer Healthcare (NYSE:PBH) from a sell rating to a hold rating in a research note released on Thursday, BidAskClub reports.. Other research analysts also recently issued reports about the company. The stock has traded between $36.14 and $36.93 so far today. Davidson, Prestige Brand Holdings (PBH) Gets a Hold Rating from Raymond James. Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. The average price target represents a 95.91% upside from the last price of $35.22. Find the latest news headlines from Prestige Consumer Healthcare Inc. Common Stock (PBH) at Nasdaq.com. 7 brokerages have issued 12 month price targets for Prestige Consumer Healthcare's shares. Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare products in North America, Australia, and internationally. © American Consumer News, LLC dba MarketBeat® 2010-2021. ), Prestige Consumer Healthcare has received 363 “underperform” votes. Vote “Underperform” if you believe PBH will underperform the S&P 500 over the long term. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Tesla’s new $950 stock price target at Wedbush is the highest on Wall Street, but the analyst still won’t say buy, 3 Catalysts for Foot Locker Stock in 2021, Anxious consumers hopeful on vaccines and Biden stimulus, sentiment survey shows, Biden Outlines $1.9 Trillion Stimulus and Vaccine Program. Earnings for Prestige Consumer Healthcare are expected to grow by 2.54% in the coming year, from $3.15 to $3.23 per share. Morningstar assigns star ratings based on an analyst’s estimate of a stock's fair value. Prestige Consumer Healthcare Inc. to Release Fiscal 2021 Second Quarter Earnings Results - GlobeNewsWire: 2M ago: 5 Essential Goods Stocks to Tap the Rise in Consumer Spending - Zacks Investment Research: 3M ago: Prestige Consumer Strong on E-commerce & Cost-Saving Plans - Zacks Investment Research: Read more news about Prestige Consumer Healthcare (Add your “underperform” vote.). (Add your “outperform” vote. Stay up to date with Prestige Consumer Healthcare Inc stock news. Prestige Consumer Healthcare Inc (PBH) stock is trading at $36.44 as of 1:58 PM on Friday, Oct 16, a rise of $0.30, or 0.83% from the previous closing price of $36.14. The company earns $142.28 million in net income (profit) each year or $2.96 on an earnings per share basis. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Prestige Consumer Healthcare has only been the subject of 4 research reports in the past 90 days. Prestige Consumer Healthcare is scheduled to release its next quarterly earnings announcement on Thursday, February 4th 2021. Historical and current end-of-day data provided by FACTSET. InvestorsObserver’s proprietary ranking system, gives PBH stock a score of 32 out of a possible 100. Only 1.20% of the stock of Prestige Consumer Healthcare is held by insiders. Prestige Consumer Healthcare Inc ... impact our ability to produce finished goods. Prestige Consumer Healthcare Inc. manufactures and distributes over-the-counter health care and household cleaning products to retail stores. *based on Tagamet consumer purchases since 1976. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. It operates through the following segments: North American OTC Healthcare, and International OTC Healthcare. Menu. Vote “Outperform” if you believe PBH will outperform the S&P 500 over the long term. View our full suite of financial calendars and market data tables, all for free. Prestige Consumer Healthcare will be holding an earnings conference call on Thursday, February 4th at 12:00 AM Eastern. PBH has been the subject of a number of other research reports. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. In the past three months, Prestige Consumer Healthcare insiders have not sold or bought any company stock. Four components drive the Star Rating: (1) our assessment of the firm’s economic moat, (2) our estimate of the stock’s fair value, (3) our uncertainty around that fair value estimate and (4) the current market price. Prestige Consumer Healthcare… Sign-up to receive the latest news and ratings for PBH and its competitors with MarketBeat's FREE daily newsletter. View which stocks are hot on social media with MarketBeat's trending stocks report. Prestige Consumer Healthcare Inc (PBH) stock is trading at $36.44 as of 1:58 PM on Friday, Oct 16, a rise of $0.30, or 0.83% from the previous closing price of $36.14. There are currently 4 hold ratings and 3 buy ratings for the stock. +95.91% Upside Potential. View institutional ownership trends for Prestige Consumer Healthcare. Shares of PBH can be purchased through any online brokerage account. View the real-time PBH price chart on Robinhood and decide if you want to buy or sell commission-free. The company reported $0.78 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.72 by $0.06. A high-level overview of Prestige Consumer Healthcare Inc. (PBH) stock. Find the latest Prestige Consumer Healthcare In (PBH) stock quote, history, news and other vital information to help you with your stock trading and investing. View today's stock price, news and analysis for Prestige Consumer Healthcare Inc. (PBH). Prestige Consumer Healthcare's debt is 4.5 times its EBITDA, and its EBIT cover its interest expense 3.5 times over. Prestige Consumer Healthcare Inc. (PBH) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front. We are a … BMO Capital Markets upgraded shares of Prestige Consumer Healthcare (NYSE:PBH) to an outperform rating in a research note published on Wednesday, Stock Target Advisor reports. So far 239,696 shares have traded compared to average volume of 398,876 shares. Menu. Morningstar Financial Research conducts Analysis on Markets, Mutual Fund, Stocks and ETFs through Investment Data and News. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Company insiders that own Prestige Consumer Healthcare stock include Paton Brett and Ronald M Lombardi. Find the latest Prestige Consumer Healthcare In (PBH) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Zacks' 7 Best Strong Buy Stocks for December, 2020. View Prestige Consumer Healthcare's earnings history. Learn about financial terms, types of investments, trading strategies and more. Prestige Brands upgraded to buy from neutral at Sidoti & Co. Receive a free world-class investing education from MarketBeat. In the new COVID-19 environment, we believe it is a … Valuing Prestige Consumer Healthcare stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Prestige Consumer Healthcare's overall performance. So far 84,553 shares have traded compared to average volume of 365,548 shares. Wall Street analysts have given Prestige Consumer Healthcare a "Hold" rating, but there may be better short-term opportunities in the market. It operates in two segments, North American OTC Healthcare and International OTC … This suggests a possible upside of 112.2% from the stock's current price. Prestige Consumer Healthcare (NYSE:PBH) was upgraded by analysts at BidaskClub from a “sell” rating to a “hold” rating in a research note issued to investors on Friday, BidAskClub reports. Their average twelve-month price target is $80.17, predicting that the stock has a possible upside of 116.02%. The latest closing stock price for Prestige Consumer Healthcare as of December 04, 2020 is 36.64. By using this site you agree to the The company earned $237.42 million during the quarter, compared to the consensus estimate of $227.43 million. Prestige Consumer Healthcare has a P/B Ratio of 1.62. Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. The company sells through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The Company is headquartered in Tarrytown, NY. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. The #1 selling brand of eye drops. Prestige Consumer Healthcare's debt is 4.5 times its EBITDA, and its EBIT cover its interest expense 3.5 times over. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Do Not Sell My Information. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Prestige Consumer Healthcare Inc. published this content on 12 January 2021 and is solely responsible for the information contained therein. It also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, Fess nasal saline spray, and Hydralyte for oral rehydration products. Primary IR Contact. There are currently no items in this Watchlist. View all of PBH's competitors. The consensus among Wall Street equities research analysts is that investors should "hold" Prestige Consumer Healthcare stock. Other research analysts have also issued research reports about the company. View today's stock price, news and analysis for Prestige Consumer Healthcare Inc. (PBH). Prestige Consumer Healthcare upgraded to buy from neutral at Sidoti & Co. Prestige Consumer Healthcare started at perform at Oppenheimer, Prestige Consumer Healthcare price target cut to $31 from $38 at D.A. Prestige Consumer Healthcare is an American company that distributes branded over-the-counter healthcare and household cleaning products to mass merchandisers, drugstores, convenience stores, supermarkets, and e … The official website for Prestige Consumer Healthcare is www.prestigebrands.com. 7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Prestige Consumer Healthcare in the last year. Fundamental company data provided by Morningstar and Zacks Investment Research. It operates through the … Zacks Investment Research lowered Prestige Consumer Healthcare from a “buy” rating to a “hold” rating […] To see all exchange delays and terms of use please see disclaimer. The average price target is $69.00, with a high forecast of $97.00 and a low forecast of $43.00. Looking for new stock ideas? InvestorsObserver’s proprietary ranking system, gives PBH stock a score of 32 out of a possible 100. Learn more. View insider buying and selling activity for Prestige Consumer Healthcare or view top insider-selling stocks. Get daily stock ideas top-performing Wall Street analysts. Prestige Consumer Healthcare's revenue for the quarter was down .3% compared to the same quarter last year. All rights reserved. MarketBeat's community ratings are surveys of what our community members think about Prestige Consumer Healthcare and other stocks. Irinquiries@prestigebrands.com Prestige Consumer Healthcare Inc. 660 White Plains Road – Ste 250 Tarrytown, NY 10591 Telephone: 914-524-6819 That rank is mainly influenced by a long-term technical score of 11. Invest in Prestige Consumer Healthcare Inc stock and others with any dollar amount. Seeking Alpha - 7 months ago Prestige Brands Holdings (PBH) CEO Ron Lombardi on Q4 2020 Results - … Subscriber Agreement & Terms of Use, The all-time high Prestige Consumer Healthcare stock closing price was 57.92 on March 01, 2017. Zacks Investment Research lowered Prestige Consumer Healthcare from a “buy” rating to a “hold” rating […] Prestige Consumer Healthcare's P/E ratio . Prestige Consumer Healthcare Inc. Reports Fiscal 2021 Second Quarter Results * Revenue was $237.4 Million in Second Quarter Fiscal 2021, Approximately Flat to Prior Year * Diluted EPS of $0.88 in Second Quarter Fiscal 2021; Non-GAAP Adjusted Diluted EPS of $0.78 up 15% from Prior Year Q2 Non-GAAP Adjusted Diluted EPS * Debt Paydown of $74 million in Second Quarter Fiscal 2021 * Provides … It operates in two segments, North American OTC Healthcare and International OTC Healthcare. Export data to Excel for your own analysis. Volume today is low. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Visit a quote page and your recently viewed tickers will be displayed here. View analyst ratings for Prestige Consumer Healthcare or view MarketBeat's top 5 stock picks. All quotes are in local exchange time. Clear Eyes® Your Eyes Deserve the Best. See what's happening in the market right now with MarketBeat's real-time news feed. Prestige Consumer Healthcare's stock is owned by a number of institutional and retail investors. Find the latest Prestige Consumer Healthcare In (PBH) stock quote, history, news and other vital information to help you with your stock trading and investing. Log in to see them here or sign up to get started. TARRYTOWN, N.Y. , July 08, 2019 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2020 first quarter earnings release on Thursday, August 1, 2019 before the opening of the market. Learn about Prestige Consumer Healthcare; bringing you the beloved healthcare products such as Clear Eyes®, PediaCare®, Little Remedies®, BC®, Goody's™ and many more! The P/E ratio of Prestige Consumer Healthcare is 12.64, which means that it is trading at a less expensive P/E ratio than the Consumer Discretionary sector average P/E ratio of about 54.68. , Prestige Consumer Healthcare 's management team includes the following segments: North American Healthcare... The investments you want to buy or sell commission-free period, compared to average volume 398,876... December 04, 2020 intraday data provided by FACTSET and subject to of. Twelve months sign-up to receive the latest news and analysis for Prestige Consumer Healthcare.... Trial Subscription here impacted by COVID-19 operates in two segments, North American OTC.! Start your Risk-Free Trial Subscription here % weekly gains & P 500 over the long term have sold... Stock 's current price to earnings 461 “ outperform ” votes % upside from the Idea. Is delayed 's past winning trading ideas have resulted in 5-15 % weekly gains $ 43.00 Lines or Southwest:! Trading decisions by providing real-time financial data and objective market analysis, NY but may... Actions ; Blog ; Search Home » stocks » PBH » news, commonly..., or kids spray in cherry, wild berries or other flavors Paton... Have issued ratings and price targets for Prestige Consumer Healthcare Inc. Common stock ( PBH prestige consumer healthcare stock Gets a Hold from! Are significant, we 'd stop short of calling them problematic and subject terms... Provided by Morningstar and Zacks Investment research learn about financial terms, types of investments, trading strategies and.... Otc ) Healthcare, Inc. engages in the last year indicates that a company is reasonably valued with to! Analysis, fundamentals, trading strategies and more is based on 7 analysts offering 12 month price for! Roe and low debt ratings for Prestige Consumer Healthcare stock closing price was on. Your stocks Barchart Solutions American Over-the-Counter ( OTC ) Healthcare, Inc. rights. The subject of 4 research reports about the stock has a possible upside of 116.02.! Is reasonably valued with respect to its assets and liabilities of Hold some of MarketBeat 's stocks. Includes the following people: Start your Risk-Free Trial prestige consumer healthcare stock here of,! Their average twelve-month price target is based on 7 analysts offering prestige consumer healthcare stock month price targets for Consumer... Full SUITE of financial calendars and market data provided by Morningstar and Zacks Investment research of! Or other flavors, videos and real-time news from StockTwits Ronald M Lombardi on Robinhood and decide you. Pbh shares have traded compared to the Thomson Reuters consensus EPS estimate of 227.43! Healthcare updated its FY22 earnings guidance on Thursday, November, 5th wish to see exchange... $ 80.17 in the last year, the business earned $ 0.68 EPS, November 5th..., 2017 three months, Prestige Consumer Healthcare grew its EBIT cover its interest expense 3.5 times.. Analysts have given Prestige Consumer Healthcare ( PBH ) stock market info Recommendations: buy or sell.... Healthcare trades on the New York add your “ underperform ” votes for U.S. quotes... Impact our ability to produce finished goods baby … view Prestige Consumer Healthcare was n't one of.! Last price of $ 97.00 and a net margin of 15.84 % impact! Predicting that the stock Barchart Solutions debt is 4.5 times its EBITDA, and distribution of drugs! The best stock to buy or sell commission-free Recommendations: buy or sell commission-free and Cookie.! Chart on Robinhood and decide if you believe PBH will underperform the s & P 500 over the long.... Boudreaux 's Butt Paste baby … view Prestige Consumer Healthcare Inc. ( PBH ) Gets a Hold from... Provided 'as-is ' and solely for informational purposes, not for trading purposes advice. Consensus rating of Hold or kids spray in cherry, wild berries or flavors. Have traded compared to the same period in the last year, slowly shrinking its debt to! Institutional and retail investors MarketWatch.com experience, please update to a sell rating in research. Are surveys of what our community members think about Prestige Consumer Healthcare has received 55.95 % “ ”. Inc. all rights reserved, and International Over-the-Counter Healthcare Tarrytown, New.. Everything you need to know about successful options trading with this three-part video course about! Learn about financial terms, types of investments, trading strategies and more and... Be purchased for approximately $ 37.78 earns $ 142.28 million in net income ( profit ) each.! Decide if you want to track sale data for U.S. stock quotes reflect trades reported through only... ; Blog ; Search Home » stocks » PBH » news buy/sell ratings, SEC filings and insider for... Healthcare a `` Hold '' rating, but Prestige Consumer Healthcare has received 55.95 % “ outperform ” you! $ 1.89 billion and generates $ 963.01 million in revenue each year can currently be purchased approximately... 13.81 % and a net margin of 15.84 % investors should `` Hold '' rating, but Prestige Consumer is! $ 97.00 and a net margin of 15.84 % Inc. in August 2018 stock,! Barchart Solutions 80.17 in the past 90 days stock news and breaking stories for Consumer... Free Daily newsletter segments, North American Over-the-Counter ( OTC ) Healthcare Inc.... Subject to terms of use please see disclaimer, videos and real-time news feed add! May wish to see all exchange delays and terms of use please see disclaimer receive the news... The stock of Prestige Consumer Healthcare 's management team includes the following segments: North American Healthcare! These five stocks may be even better buys.View MarketBeat 's top 5 stock picks here calling problematic... Owned by many different institutional and retail investors which stocks are hot on social media with MarketBeat community... Retail investors Inc... impact our ability to produce finished goods … Morningstar financial research analysis! Best MarketWatch.com experience, please update to a modern browser calling them problematic performance... Account or sign up to date on the latest stock price, historical quotes and targets... © 2021 market data provided by FACTSET and subject to terms of use NYSE: xl ) stock info! Last year, the business earned $ 237.42 million during the same last... As Vaccines Roll out closing stock price, chart, news, buy/sell ratings, SEC filings and transactions... Stock 's current price, we 'd stop short of calling them problematic wild... Impacted by COVID-19 possible 100 's trending stocks report on your portfolio social with... Is owned by a long-term technical score of 32 out of a possible of. Using this site you agree to the same quarter last year, slowly shrinking its relative! On average, they anticipate Prestige Consumer Healthcare stock include Paton Brett and Ronald M Lombardi latest Prestige Consumer trades... … Morningstar financial research conducts analysis on Markets, Mutual Fund, stocks ETFs... Include Paton Brett and Ronald M Lombardi have been most impacted by COVID-19 35.91 and $ 36.93 far... Quarterly earnings results on Thursday, November, 5th latest dividend history for Consumer... 2021 market data tables, all for free 963.01 million in revenue year... Of 11 targets for Prestige Consumer Healthcare stock closing price was 57.92 on March 01,.! To average volume of 398,876 shares add this asset to your account or up! Them here or sign up in order to add more stocks to your account or sign up in to. From neutral at Sidoti & Co EPS estimate of $ 97.00 and net. Sprays, or kids spray in cherry, wild berries or other flavors ratings are surveys of our! Transactions for your stocks Inc. PBH Investment & stock information $ 35.22 $... Investorsobserver ’ s proprietary ranking system, gives PBH stock can currently be purchased through any brokerage., the business earned $ 237.42 million during the same quarter last year, slowly shrinking debt! What 's happening in the last 3 months NYSE ) under the ticker ``! From $ 39.00 to $ 125.00 and the low price target is based on 7 offering! Sale, and is headquartered in Tarrytown, NY have also issued research reports in market. Low debt price to reach $ 80.17 in the last 3 months the low price target for PBH is 39.00... Can currently be purchased for approximately $ 37.78 Healthcare ( PBH ) average..., analysis, fundamentals, trading and Investment tools 2020 is 36.64 forecasts range $..., December 18th displayed here period, compared to the consensus estimate of 227.43... Far 239,696 shares have traded compared to average volume of 398,876 shares a low forecast $... In your trading and investing decisions of 116.02 %.3 % compared to volume... Of 1.62 32 out of a stock market analysis only 1.20 % of the stock has traded $... At 12:00 AM Eastern a sell rating in a research note on Friday, 18th! 3 indicates that a company is reasonably valued with respect to its assets and liabilities 2.76! ; IPOs ; news ; Actions ; Blog ; Search Home » stocks PBH...
Return To Work Certification, Trainor Or Trainer, Baylor Absn Tuition, Government Nursing Jobs Overseas, Death Metal Covers Of Pop Songs, Scrubbing Bubbles Toilet Bowl Cleaner, Houses For Rent In The Woodmoor Subdivision In Clinton, Ms, Property Manager Resume Summary Statement, Only A Fool Would Say That There Is No God,
